Acadia Pharmaceuticals Inc. is a biopharmaceutical company at the forefront of developing and commercializing innovative small molecule drugs for central nervous system (CNS) disorders. We currently focus on our lead product, pimavanserin, which is approved for treating hallucinations and delusions associated with Parkinson's disease psychosis and for Rett syndrome. Our unique value proposition lies in our commitment to addressing unmet medical needs in the neuroscience space, fostering a collaborative environment for groundbreaking research, and bringing critical solutions to patients. Our technology stack supports our research and development, clinical trials, and commercial operations. We utilize advanced technologies including SPF, SSL by Default, DNSSEC, and Cloudflare CDN to ensure the security and reliability of our digital infrastructure. Our remote-first approach helps us support our global presence, including our wholly owned subsidiaries in Sweden and Denmark. Acadia boasts a dynamic and driven culture, with a commitment to innovation and patient impact. Our team of 501-1000 employees works collaboratively to push the boundaries of neuroscience. We are a publicly traded company (NASDAQ:ACAD) with significant funding, allowing us to invest heavily in research and development, and expand our late-stage pipeline targeting neuro-psychiatric and neuro-rare diseases. We are committed to attracting, retaining, and developing talented people from diverse backgrounds. We are currently experiencing a period of significant growth, with several product candidates in the development pipeline, including therapies for Prader-Willi syndrome and Alzheimer's disease psychosis. This rapid expansion presents numerous exciting career opportunities for talented individuals looking to make a difference in the lives of patients.
VideaHealth is revolutionizing dental care with its AI-powered software that automatically detects pathologies in dental imaging. Developed by a team of engineers, AI scientists, and clinicians, our software helps dentists avoid missing diseases, leading to faster diagnoses and improved patient outcomes. We're at the forefront of healthcare innovation, aiming to be the first company to diagnose a billion people globally. Our tech stack includes DNSSEC, Organization Schema, IPv6, Cloudflare, Person Schema, and Amazon S3, among other technologies, reflecting our commitment to a robust and scalable infrastructure. VideaHealth is backed by leading investors like Spark Capital and Zetta Venture Partners, and we've secured over $67M in Venture Capital. With a remote-first culture and a collaborative environment, we foster innovation and growth. Our engineers are driven by the impact of our work and the opportunity to contribute to a rapidly growing company. We offer a unique opportunity to be part of a company that is making a tangible difference in the healthcare industry. We believe in an equitable, inclusive, and supportive environment for all employees, creating a safe space for everyone to share their experiences, brainstorm ideas, and grow their careers.
Entrada Therapeutics is a clinical-stage biopharmaceutical company pioneering a novel approach to treating devastating diseases. We develop Endosomal Escape Vehicle (EEV™) therapeutics, designed for efficient intracellular delivery of proteins, peptides, and nucleic acids, overcoming limitations of traditional large and small molecule therapies. This innovative technology allows us to target previously inaccessible intracellular pathways, advancing a robust portfolio of RNA-, antibody-, and enzyme-based programs for neuromuscular, ocular, metabolic, and immunological diseases. Our lead oligonucleotide programs are in development for Duchenne muscular dystrophy, and we've partnered on a clinical-stage program for myotonic dystrophy type 1. Entrada operates with a strong tech foundation, utilizing technologies such as Drupal 10, Akamai EdgeWorkers, and BunnyCDN Header for our web infrastructure and various other technologies for streamlining internal processes. Our engineering culture fosters collaboration and innovation, valuing a balance between cutting-edge technology and patient-focused results. We pride ourselves on our values of Humanity, Tenacity, Creativity, Collaboration, and Curiosity – these principles guide our work and interactions. We're a dynamic team of experts in therapeutic development and rare diseases, currently employing 101-250 people and headquartered in Boston, MA. With significant funding secured and a growing pipeline of promising therapies, Entrada is poised for continued growth and expansion. We offer a variety of remote work opportunities and employee benefits designed to support a positive work-life balance. Entrada is an equal opportunity employer committed to fostering a diverse and inclusive workplace. We encourage candidates from all backgrounds to apply.
Eikon Therapeutics is a biopharmaceutical company at the forefront of drug discovery, leveraging groundbreaking technologies to identify novel treatments for life-threatening diseases. Our platform centers on live-cell resolution microscopy and advanced engineering, allowing us to measure protein movement in living cells with unprecedented precision. This innovation unlocks access to otherwise intractable protein targets, accelerating the development of new therapies. We're pushing the boundaries of what's possible in the life sciences, and our engineering team is key to this mission. Our tech stack includes Domain Not Resolving, DNSSEC, IPv6, Cloudflare JS, CDN JS, Cloudflare Hosting, Microsoft, Amazon Route 53, Amazon CloudFront, and ATT. We champion a collaborative, fast-paced, and highly matrixed work environment. This allows us to build cutting-edge hardware and software solutions, including custom-built instruments and AI-powered data analysis tools. Eikon Therapeutics is a rapidly growing company, backed by $1.12 billion in funding, and we have a global presence with remote opportunities in various locations. We offer a rich benefits package, including excellent medical, dental, and vision coverage, a 401k plan with company matching, generous time off, and programs supporting employee well-being. Join us and become part of a team dedicated to making a real impact on human health.
Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies to address significant market opportunities, primarily in ophthalmic conditions. Our lead product candidate, TP-03, is a novel therapeutic currently in Phase 2b/3 clinical trials for the treatment of Demodex blepharitis, showcasing our commitment to addressing unmet medical needs. As a company of 101-250 employees, we leverage a robust tech stack including DNSSEC, Amazon Web Services (AWS) for cloud infrastructure, and BootstrapCDN for content delivery, ensuring a mobile-optimized experience for our users. We operate in a hybrid work environment and offer remote work options for many roles. Our culture thrives on commitment to patients, empowering innovation, and teamwork to amplify impact. We are a publicly traded company (NASDAQ:TARS), and our Series B funding round helped us to accelerate our research and development efforts. Our team is passionate about our mission to create category-creating products and is empowered to champion innovation. We have built a team of experts in ophthalmology and other therapeutic categories, with a focus on delivering on our promise to patients. Tarsus Pharmaceuticals is dedicated to attracting and retaining top talent by providing competitive compensation, including a comprehensive benefits package, stock equity and ensuring work-life balance through generous paid time off.
Disc Medicine is a clinical-stage biopharmaceutical company at the forefront of hematologic disease treatment. We are dedicated to discovering, developing, and commercializing novel therapies for patients with severe hematologic disorders, with our pipeline focused on innovative treatments like bitopertin. Our commitment lies in targeting fundamental biological pathways and developing first-in-class therapeutic candidates. Our tech stack supports our mission with platforms like Drupal, Akamai EdgeWorkers, and Adobe Dynamic Tag Management. We leverage technologies like HSTS, Google Maps, and mobile optimization to ensure our digital infrastructure is robust and accessible. Our engineering culture is collaborative, and we value scientific integrity. We are growing rapidly and committed to technological innovation to advance our research and development efforts. We are a publicly traded company with strong financial backing and a focus on attracting talented professionals. We offer a hybrid work environment, and our Watertown, MA, headquarters provides a collaborative setting. At Disc Medicine, we foster an inclusive company culture that promotes professional development and empowers our employees. We're seeking individuals with an entrepreneurial spirit and a drive for excellence to join our team and help us make a difference in patients' lives.
Roivant Sciences is a biopharmaceutical company accelerating the development of promising late-stage drug candidates. We achieve this by building and supporting nimble, entrepreneurial biotech companies (Vants), leveraging a unique approach to talent acquisition, incentive alignment, and technology deployment. Our focus is on reducing the time and cost of bringing new medicines to market, ultimately improving patient lives and benefiting the healthcare system. We've successfully launched VTAMA®, achieved multiple FDA approvals, and secured significant global partnerships. This rapid growth has been fueled by strategic in-licensing, acquisitions, and a commitment to innovation. Our tech-enabled approach is central to our success. We utilize a robust technology stack including iPhone/Mobile compatibility, Google Tag Manager, Google Analytics, and a Content Delivery Network (CDN), ensuring efficient data management and streamlined operations. We foster a dynamic, collaborative environment, embracing both remote and in-person work models. Our engineering culture values agility, innovation, and a data-driven approach to problem-solving. Roivant's mission is to dramatically improve healthcare outcomes. We are a large company, currently employing between 501 and 1000 people, and we strive to create a rewarding and impactful workplace. We value both individual achievement and collaborative teamwork. We offer a range of exciting opportunities across multiple therapeutic areas, in both clinical development and tech-focused operations. Our significant funding and consistent success position us for continued growth and leadership in the biopharmaceutical industry. Roivant prioritizes diversity, equity, and inclusion. We are proud of our diverse workforce and offer a supportive and inclusive environment where every employee's contributions are valued. We embrace remote work, offering flexibility and empowering employees to perform at their best, regardless of location. With offices globally, we're a dynamic organization continually seeking talented and passionate individuals to join our mission.
Biofourmis is a leading biotechnology company revolutionizing personalized healthcare through digital therapeutics. We develop and deliver clinically validated software solutions that improve patient outcomes, providing advanced tools for clinicians and cost-effective solutions for payers. Our platform integrates continuous and episodic patient monitoring with AI-driven analytics, enabling proactive and personalized care delivery in the home setting. This approach is transforming traditional healthcare models, expanding access to high-quality care and improving overall patient experience. Our tech stack leverages a robust combination of technologies, including Envoy, Hubspot, and Cloudflare, alongside core infrastructure components like DNSSEC and IPv6. We maintain a strong focus on secure data handling and HIPAA compliance. Our engineering team values innovation, collaboration, and a commitment to building scalable, reliable solutions that positively impact patient lives. We encourage a remote-first work environment, fostering a flexible and inclusive culture that values diverse perspectives and expertise. Biofourmis has secured significant funding, demonstrating market confidence in our approach to digital therapeutics. We've achieved considerable growth since our founding in 2015, significantly expanding our team and our impact on the healthcare landscape. We are committed to creating and sustaining a supportive, engaging, and rewarding work environment for our employees. Biofourmis is a fast-growing company with an ambitious vision for the future of healthcare. If you're looking for a challenging and rewarding career where you can make a real difference in the lives of others, we encourage you to explore our open positions.
Dianthus Therapeutics is a clinical-stage biotechnology company pioneering novel monoclonal antibody treatments for severe autoimmune and inflammatory diseases. Our lead product, DNTH103, targets a specific part of the immune system and is designed for self-administration in some patients. We're making a significant impact in the biopharma industry by focusing on improved selectivity and potency, leading to more effective and targeted therapies. Our tech stack includes a robust mix of modern technologies such as Cloudflare JS, Google Cloud, and Cloudinary, reflecting our commitment to efficient and scalable development. We foster a collaborative engineering culture that embraces innovative approaches and prioritizes data-driven decision-making. We value scientific integrity, continuous learning, and a dedication to improving patient lives. We offer remote work opportunities and support a diverse and inclusive environment. Dianthus is a publicly traded company (NASDAQ: DNTH) with a strong funding history and a growing team of experienced professionals in biotech and pharma. We are actively expanding our team to support the advancement of DNTH103 through clinical trials and eventual commercialization. Join us in our mission to bring life-changing treatments to patients battling serious autoimmune diseases. We offer a supportive and flexible work environment which embraces remote work. Join our growing team and make a significant impact on the lives of patients suffering from autoimmune diseases. We are committed to providing transformative medicines for people living with severe autoimmune and inflammatory diseases.